01 1Ipca Laboratories
01 1ATENOLOL USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-01-22
Pay. Date : 2024-01-17
DMF Number : 15037
Submission : 2000-09-08
Status : Active
Type : II
20
Ipca Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ATENOLOL USP, with a corresponding US DMF Number 15037.
Remarkably, this DMF maintains an Active status since its submission on September 08, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 22, 2024, and payment made on January 17, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
